CardioVascular BioTherapeutics, Inc. (OTCBB:CVBT) today announced it is featured in a BusinessWeek Online article that highlights the race within the biotech industry to develop an angiogenesis treatment for patients with heart disease. Angiogenesis refers to the growth of new blood vessels that may help those suffering from coronary heart disease by alleviating the decreased blood flow associated with the disease. The article can be viewed at: http://www.businessweek.com/technology/content/jul2007/tc2007075_25959 8.htm?chan=top+news_top+news+index_technology (Due to its length, this URL may need to be copied/pasted into your Internet browser’s address field. Remove the extra space if one exists.)